首页> 外文期刊>BMC Nephrology >Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study
【24h】

Effect of plasma sodium concentration on blood pressure regulators during hemodialysis: a randomized crossover study

机译:血液透析期间血浆钠浓度对血压调节剂的影响:一项随机交叉研究

获取原文
       

摘要

Intradialytic hypotension is a common complication of hemodialysis. The Hemocontrol biofeedback system, improving intradialytic hemodynamic stability, is associated with an initial transient increase in plasma sodium levels. Increases in sodium could affect blood pressure regulators. We investigated whether Hemocontrol dialysis affects vasopressin and copeptin levels, endothelial function, and sympathetic activity in twenty-nine chronic hemodialysis patients. Each patient underwent one standard hemodialysis and one Hemocontrol hemodialysis. Plasma sodium, osmolality, nitrite and nitrate (NOx), endothelin-1, angiopoietins-1 and 2, and methemoglobin as measures of endothelial function, plasma catecholamines as indices of sympathetic activity and plasma vasopressin and copeptin levels were measured six times during each modality. Blood pressure, heart rate, blood volume, and heart rate variability were repeatedly monitored. Generalized Estimating Equations was used to compare the course of the parameters during the two treatment modalities. Plasma sodium and osmolality were significantly higher during the first two hours of Hemocontrol hemodialysis. Overall, mean arterial pressure (MAP) was higher during Hemocontrol dialysis. Neither the measures of endothelial function and sympathetic activity nor copeptin levels differed between the two dialysis modalities. In contrast, plasma vasopressin levels were significantly higher during the first half of Hemocontrol dialysis. The intradialytic course of vasopressin was associated with the course of MAP. A transient intradialytic increase in plasma sodium did not affect indices of endothelial function or sympathetic activity compared with standard hemodialysis, but coincided with higher plasma vasopressin levels. The beneficial effect of higher intradialytic sodium levels on hemodynamic stability might be mediated by vasopressin. ClinicalTrials.gov. Identifier: NCT03578510 . Date of registration: July 5th, 2018. Retrospectively registered.
机译:透析内低血压是血液透析的常见并发症。 Hemocontrol生物反馈系统改善了透析内的血液动力学稳定性,并与血浆钠水平的最初短暂升高有关。钠的增加可能会影响血压调节器。我们调查了血液控制透析是否影响29例慢性血液透析患者的血管加压素和胶原蛋白水平,内皮功能和交感神经活动。每位患者均进行了一次标准血液透析和一次Hemocontrol血液透析。血浆钠,重量克分子渗透压浓度,亚硝酸盐和硝酸盐(NOx),内皮素-1,血管生成素-1和2,高铁血红蛋白作为衡量内皮功能的指标,血浆儿茶酚胺作为交感神经活性的指标以及血浆血管加压素和肽素的水平在每种模式下进行六次测量。重复监测血压,心率,血容量和心率变异性。广义估计方程用于比较两种治疗方式中参数的变化过程。在血液控制血液透析的前两个小时内,血浆钠和渗透压明显升高。总体而言,血液控制透析期间的平均动脉压(MAP)较高。两种透析方式之间的内皮功能和交感活性的测定以及肽素水平都没有差异。相反,在血液控制透析的前半段中,血浆加压素水平显着较高。血管加压素的透析过程与MAP的过程有关。与标准血液透析相比,血浆钠的瞬时透析内增加不影响内皮功能或交感神经活动指数,但与血浆加压素水平较高相吻合。透析中较高的钠水平对血液动力学稳定性的有益作用可能是加压素介导的。 ClinicalTrials.gov。标识符:NCT03578510。注册日期:2018年7月5日。追溯注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号